A biopharmaceutical company
Prescription Drug User Fee Act reauthorization.
Diabetes drugs issues.
H.R. 5651, Food and Drug Administration Reform Act of 2012.
S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act.
S. 2292, Patients' FDA Act.
H.R. 6433, FDA User Fee Corrections Act of 2012.
"Track and trace" issues. Diabetes research issues. Diabetes issues.
Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Medicare coverage and reimbursement issues.
Diabetes issues.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
H.R. 6684, Spending Reduction Act of 2012.
H.R. 8, American Taxpayer Relief Act of 2012.
PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
PODESTA GROUP, INC.
1001 G Street, NW, Suite 1000 West, Washington, DC, 20001, US
SHARON COHEN THOMAS B SPARKMAN SHARON COHEN SHARON COHEN SHARON COHEN